Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Advances in Experimental Medicine and Biology
|
April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 Inhibitors
John Koren, Brian S J Blagg
The American Journal of Pathology
|
October 4, 2011
The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed
Kellen Voss, John Koren, Chad A Dickey
Frontiers in Neuroscience
|
January 10, 2018
Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies
Lindsey B Shelton, John Koren, Laura J Blair
Current Enzyme Inhibition
|
June 27, 2013
Reconstructing the Hsp90/Tau Machine
Umesh K Jinwal, John Koren, Chad A Dickey
Journal of Molecular Neuroscience : MN
|
May 12, 2011
Neuronal life span versus health span: principles of natural selection at work in the degenerating brain
John C O'Leary, John Koren, Chad A Dickey
Current Alzheimer Research
|
November 21, 2013
Regulatory chaperone complexes in neurodegenerative diseases: a perspective on therapeutic intervention
Aaron Carman, Sarah Kishinevsky, John Koren, et al.
Journal of Alzheimer'S Disease & Parkinsonism
|
September 27, 2014
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
Aaron Carman, Sarah Kishinevsky, John Koren, et al.
Experimental Neurology
|
May 24, 2021
Effects of altered tau expression on dentate granule cell excitability in mice
Ryan A Cloyd, John Koren, Jose F Abisambra, et al.
Current Topics in Medicinal Chemistry
|
April 14, 2016
Stressing Out Hsp90 in Neurotoxic Proteinopathies
Carmen Inda, Alexander Bolaender, Tai Wang, et al.
Future Medicinal Chemistry
|
September 3, 2011
Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies
Yoshinari Miyata, John Koren, Janine Kiray, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Advances in Experimental Medicine and Biology
|
April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 Inhibitors
John Koren, Brian S J Blagg
The American Journal of Pathology
|
October 4, 2011
The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed
Kellen Voss, John Koren, Chad A Dickey
Frontiers in Neuroscience
|
January 10, 2018
Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies
Lindsey B Shelton, John Koren, Laura J Blair
Current Enzyme Inhibition
|
June 27, 2013
Reconstructing the Hsp90/Tau Machine
Umesh K Jinwal, John Koren, Chad A Dickey
Journal of Molecular Neuroscience : MN
|
May 12, 2011
Neuronal life span versus health span: principles of natural selection at work in the degenerating brain
John C O'Leary, John Koren, Chad A Dickey
Current Alzheimer Research
|
November 21, 2013
Regulatory chaperone complexes in neurodegenerative diseases: a perspective on therapeutic intervention
Aaron Carman, Sarah Kishinevsky, John Koren, et al.
Journal of Alzheimer'S Disease & Parkinsonism
|
September 27, 2014
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
Aaron Carman, Sarah Kishinevsky, John Koren, et al.
Experimental Neurology
|
May 24, 2021
Effects of altered tau expression on dentate granule cell excitability in mice
Ryan A Cloyd, John Koren, Jose F Abisambra, et al.
Current Topics in Medicinal Chemistry
|
April 14, 2016
Stressing Out Hsp90 in Neurotoxic Proteinopathies
Carmen Inda, Alexander Bolaender, Tai Wang, et al.
Future Medicinal Chemistry
|
September 3, 2011
Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies
Yoshinari Miyata, John Koren, Janine Kiray, et al.
Page
of 5